Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a open-label dose-finding study of sotatercept in adults with beta-thalassemia
2011-005659-15Phase 2Unknown
- Sponsor
- Celgene Corporation
- Start
- Jul 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sotatercept in beta thalassemia, beta-thalassemia intermedia, sponsored by Celgene Corporation. Status: unknown.
02
Drugs
sotatercept
03
Conditions
beta thalassemiabeta-thalassemia intermedia
Beyond the preview
Go deeper on 2011-005659-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005659-15.